![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vericel Corporation | NASDAQ:VCEL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.44 | 4.89% | 52.29 | 52.29 | 52.34 | 52.71 | 49.585 | 50.66 | 322,216 | 20:58:23 |
|
Aastrom Biosciences Dominos Farms, Lobby K 24 Frank Lloyd Wright Drive Ann Arbor, MI 48105 T (800) 556-0311
www.aastrom.com |
March 22, 2012
By EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549-7010
Re: Aastrom Biosciences, Inc. Registration Statement on Form S-3 (File No. 333-180222)
Ladies and Gentlemen:
Reference is made to the registration statement on Form S-3 (File No. 333-180222) filed with the Securities and Exchange Commission (the Commission) by Aastrom Biosciences, Inc. (the Registrant) on March 19, 2012 (the Registration Statement). Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the Act), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated onto the cover page of the Registration Statement immediately following the calculation of the registration fee:
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.
If you have any questions or comments in connection with this delaying amendment, please contact Caitlin Murray (617-570-1218) of Goodwin Procter LLP.
Sincerely,
AASTROM BIOSCIENCES, INC.
By: |
/s/ Timothy M. Mayleben |
|
|
Timothy M. Mayleben |
|
|
President and Chief Executive Officer |
|
1 Year Vericel Chart |
1 Month Vericel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions